These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3923278

  • 1. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
    Miranda ML, Lissen E, Vinuesa M, Jiménez JM, García de Pesquera F, Leal M.
    Med Clin (Barc); 1985 Apr 06; 84(13):516-9. PubMed ID: 3923278
    [No Abstract] [Full Text] [Related]

  • 2. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
    Heimburger N, Karges HE, Weidmann E.
    Dev Biol Stand; 1987 Apr 06; 67():303-10. PubMed ID: 3038638
    [Abstract] [Full Text] [Related]

  • 3. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG, Renger FG.
    Z Arztl Fortbild (Jena); 1983 Apr 06; 77(19):807-10. PubMed ID: 6417919
    [No Abstract] [Full Text] [Related]

  • 4. Viral safety of plasma-derived factor VIII and IX concentrates.
    Ludlam CA.
    Blood Coagul Fibrinolysis; 1997 Aug 06; 8 Suppl 1():S19-23. PubMed ID: 9351532
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical studies with treated clotting factor concentrates.
    Colombo M, Mannucci PM.
    Dev Biol Stand; 1987 Aug 06; 67():333-6. PubMed ID: 3038639
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D, Kreuz W, Auerswald G, Auberger K, Rabenau H, Gürtler L, Roggendorf M.
    Thromb Haemost; 1995 Apr 06; 73(4):736-7. PubMed ID: 7495095
    [No Abstract] [Full Text] [Related]

  • 8. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W, Muntean W, Teubl I, Beaufort F, Heinz FX.
    Padiatr Padol; 1987 Apr 06; 22(1):33-41. PubMed ID: 3108827
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Virucidal treatment of clotting factor concentrates.
    Mannucci PM, Colombo M.
    Lancet; 1988 Oct 01; 2(8614):782-5. PubMed ID: 2901620
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP.
    Nouv Rev Fr Hematol; 1972 Oct 01; 12(2):241-9. PubMed ID: 4264617
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hemophilia, a changed picture].
    Breederveld C, ten Cate JW, Sixma JJ, Veltkamp JJ.
    Ned Tijdschr Geneeskd; 1976 Jan 10; 120(2):69-70. PubMed ID: 1250448
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Percutaneous liver biopsy in hemophiliac children with chronic hepatitis C virus infection.
    Schwarz KB, Zellos A, Stamato L, Boitnott J, Perlman E, Chong S, Casella JF.
    J Pediatr Gastroenterol Nutr; 2008 Apr 10; 46(4):423-8. PubMed ID: 18367956
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis in patients with haemophilia: introduction.
    Chambost H.
    Haemophilia; 2010 Mar 10; 16 Suppl 2():1-3. PubMed ID: 20132331
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.